05.09.2023 • News

Albemarle Makes Final Proposal for the Acquisition of Liontown

Australian lithium miner Liontown announced that it has received a revised conditional and non-binding indicative proposal from Albemarle to acquire all of the ordinary shares outstanding in Liontown for A$3.00 in cash per share via scheme of arrangement. The revised proposal values Liontown at A$6.6 billion ($4.3 billion) on an equity value basis.

The new cash offer of A$3 per share represents a 14.5% premium to Liontown's last closing price of A$2.62 on Sept. 1 and is 20% higher than Albemarle's offer of A$2.50 per share, which the company rejected as too low in late March.

Albemarle said that the revised indicative proposal is its best and final proposal, in the absence of a superior proposal.

Liontown confirmed that, subject to entry into a mutually acceptable non-disclosure and exclusivity agreement, its board intends to unanimously recommend that shareholders vote in favor of the new offer in the absence of a better offer and after an independent expert has reviewed the deal.

Source: Liontown Resources
Source: Liontown Resources

Virtual Event

Outsourced Biomanufacturing
Strategic Outsourcing in Biopharmaceuticals

Outsourced Biomanufacturing

April 22, 2026 | Join biopharma professionals, CDMO leaders, and supply chain innovators for a virtual event exploring the future of outsourced biomanufacturing.

Interview

Navigating Uncertainty and Driving Innovation
Meeting Pharma’s Demand for Speed, Reliability, and Flexibility

Navigating Uncertainty and Driving Innovation

Axplora CCO Arul Ramadurai discusses navigating industry uncertainty, building strategic partnerships, and advancing flexible pharmaceutical manufacturing

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.